Fieldfisher advises NASDAQ-listed Intersect ENT on acquisition of Fiagon AG Medical Technologies

Munich, October 7, 2020 - NASDAQ-listed Intersect ENT, Inc. acquires all shares of Fiagon AG Medical Technologies, a leading company in the field of electromagnetic surgical navigation solutions. With the transaction, which has a volume of approximately €60 million, Intersect ENT further expands its product range in the USA and Europe. Intersect ENT was advised during the takeover process by a Fieldfisher team across several offices led by the Munich partners Dr. Andreas Driver (Corporate) and Dr. Cord Willhöft (Regulatory).
The Intersect ENT, Inc. (Nasdaq: XENT) has developed a product family of absorbable, steroid-releasing paranasal sinus implants for patients with chronic sinusitis undergoing paranasal sinus surgery. With the acquisition of Fiagon AG Medical Technologies, Intersect has now taken another important step in expanding the field of use and application of its technology. The parties have agreed a purchase price of approximately 60 million euros. 
 
Legal counsel Intersect ENT, Inc:
Fieldfisher (Germany) LLP: Dr. Andreas Driver (Corporate, Partner), Dr. Cord Willhöft (Life Sciences, Partner), Dr. Stefanie Greifeneder (Commercial IP, Partner, all Munich), Andre Happel (Tax, Partner, Frankfurt), Katharina Hundemer (Life Science, Associate), Iris Lahner (Commercial, Associate, both Munich) Dr. Katja Michel (Corporate, Counsel) and Julian Funck (Tax, Associate, both Frankfurt am Main)
Cooley LLP: Steven Tonsfeldt (Corporate, Partner), Anna Maria Galinska (Corporate, Associate), both Palo Alto, CA, USA

Financial advisor Intersect ENT, Inc:
Goldman Sachs & Co. LLC

Legal adviser Fiagon AG:
Morrison & Foerster LLP: Dr. Dirk Besse (Corporate, Partner), Berlin

Financial advisor Fiagon AG:
Oppenheimer

Fieldfisher is a dynamically growing international commercial law firm with more than 800 lawyers in Belgium, China, France, Germany, Ireland, Italy, Luxembourg, Spain, UK and USA - Silicon Valley. The firm's particular focus is on the areas of finance, tech, energy & natural resources and life sciences. In addition, the firm advises companies in all sectors of the economy, from start-ups to leading global corporations, as well as the public sector.